← Back to Search

Other

ABBV-903 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by AbbVie
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 46
Awards & highlights

Study Summary

This trial looks at the effects of a single dose of a drug on the health of male volunteers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 46
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to day 46 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AUC from Time 0 to Infinite Time (AUC0-t) of ABBV-903
Area Under the Plasma Concentration-time Curve (AUC) from Time 0 to the Time of the Last Measurable Concentration (AUC0-t) of ABBV-903
Maximum observed concentration (Cmax) of ABBV-903
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ABBV-903Experimental Treatment1 Intervention
Participants will receive ABBV-903 on Day 1.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ABBV-903
2023
Completed Phase 1
~140

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

AbbVieLead Sponsor
954 Previous Clinical Trials
501,098 Total Patients Enrolled
ABBVIE INC.Study DirectorAbbVie
394 Previous Clinical Trials
145,932 Total Patients Enrolled

Media Library

ABBV-903 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05995366 — Phase 1
Healthy Subjects Research Study Groups: ABBV-903
Healthy Subjects Clinical Trial 2023: ABBV-903 Highlights & Side Effects. Trial Name: NCT05995366 — Phase 1
ABBV-903 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05995366 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How may I apply to be a part of this research endeavor?

"The requirements for enrolment into this medical trial are relatively straightforward: applicants must be physically healthy and between 18-55 years of age. Presently, there is capacity to accept around 7 volunteers."

Answered by AI

Does this medicinal investigation include individuals aged over forty?

"The parameters for eligibility to this clinical trial indicate that only those aged between 18 and 55 years old can participate. Conversely, there are 57 studies available for minors and 379 studies open to elderly patients."

Answered by AI

How many individuals are being accepted into this medical experiment?

"Affirmative, according to information hosted on clinicaltrials.gov this research project is actively searching for participants. Initially posted on August 18th 2023 and last updated on the 29th of August, this trial aims to recruit 7 individuals from a single medical centre."

Answered by AI

Has ABBV-903 achieved the necessary regulatory clearance to be marketed?

"The safety of ABBV-903 is assessed to be a 1 as this Phase 1 trial has provided insufficient data related to its efficacy and security."

Answered by AI

Are individuals able to enroll in this experiment at the present time?

"According to the clinicaltrials.gov, this medical study is presently accepting applications from suitable patients. It was initially advertised on August 18th 2023 and underwent its most recent update on August 29th 23rd."

Answered by AI
~4 spots leftby Apr 2025